Level IV tumor thrombus in non-metastatic renal cell cancer? No, thanks. Level II is better. Lessons learned from a case report

od Galosi, Andrea Benedetto, Papaveri, Alessio, Castellani, Daniele, Agostini, Edoardo, Burattini, Luciano, Dell’Atti, Lucio
izdano v Urol Case Rep (2021)

Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder

od Santoni, Matteo, Catanzariti, Francesco, Minardi, Daniele, Burattini, Luciano, Nabissi, Massimo, Muzzonigro, Giovanni, Cascinu, Stefano, Santoni, Giorgio
Izdano 2012

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma

od Conti, Alessandro, Santoni, Matteo, Amantini, Consuelo, Burattini, Luciano, Berardi, Rossana, Santoni, Giorgio, Cascinu, Stefano, Muzzonigro, Giovanni
Izdano 2013

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study

od SANTONI, MATTEO, PACCAPELO, ALESSANDRO, BURATTINI, LUCIANO, BIANCONI, MARISTELLA, CARDINALI, MASSIMO, FABBIETTI, LETIZIA, TRIGNANI, ROBERTO, RYCHLICKI, FRANCO, CASCINU, STEFANO
Izdano 2012

Seminoma Retroperitoneal Relapse 23 Years After Surgery

od Crocetti, Sonia, Tassone, Laura, Torniai, Mariangela, Pierantoni, Chiara, Burattini, Luciano, Mandolesi, Alessandra, Di Benedetto, Maika, Mantello, Giovanna, Scarpelli, Marina, Berardi, Rossana
izdano v Oncol Ther (2021)

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma

od Piva, Francesco, Giulietti, Matteo, Occhipinti, Giulia, Santoni, Matteo, Massari, Francesco, Sotte, Valeria, Iacovelli, Roberto, Burattini, Luciano, Santini, Daniele, Montironi, Rodolfo, Cascinu, Stefano, Principato, Giovanni
izdano v Oncotarget (2015)

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

od Santoni, Matteo, Scoccianti, Silvia, Lolli, Ivan, Fabrini, Maria Grazia, Silvano, Giovanni, Detti, Beatrice, Perrone, Franco, Savio, Giuseppina, Iacovelli, Roberto, Burattini, Luciano, Berardi, Rossana, Cascinu, Stefano
Izdano 2013

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas

od Santoni, Matteo, Nanni, Cristina, Bittoni, Alessandro, Polonara, Gabriele, Paccapelo, Alessandro, Trignani, Roberto, De Lisa, Mariagrazia, Rychlicki, Franco, Burattini, Luciano, Berardi, Rossana, Fanti, Stefano, Cascinu, Stefano
Izdano 2014

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma

od Bianconi, Maristella, Faloppi, Luca, Loretelli, Cristian, Zizzi, Antonio, Giampieri, Riccardo, Bittoni, Alessandro, Andrikou, Kalliopi, Prete, Michela Del, Burattini, Luciano, Montironi, Rodolfo, Scartozzi, Mario, Cascinu, Stefano
izdano v Oncotarget (2016)

Role of STAT3 pathway in genitourinary tumors

od Santoni, Matteo, Conti, Alessandro, Piva, Francesco, Massari, Francesco, Ciccarese, Chiara, Burattini, Luciano, Cheng, Liang, Lopez-Beltran, Antonio, Scarpelli, Marina, Santini, Daniele, Tortora, Giampaolo, Cascinu, Stefano, Montironi, Rodolfo
izdano v Future Sci OA (2015)

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

od Santini, Daniele, Santoni, Matteo, Conti, Alessandro, Procopio, Giuseppe, Verzoni, Elena, Galli, Luca, di Lorenzo, Giuseppe, De Giorgi, Ugo, De Lisi, Delia, Nicodemo, Maurizio, Maruzzo, Marco, Massari, Francesco, Buti, Sebastiano, Altobelli, Emanuela, Biasco, Elisa, Ricotta, Riccardo, Porta, Camillo, Vincenzi, Bruno, Papalia, Rocco, Marchetti, Paolo, Burattini, Luciano, Berardi, Rossana, Muto, Giovanni, Montironi, Rodolfo, Cascinu, Stefano, Tonini, Giuseppe
izdano v Oncotarget (2016)